Portal de investigación
ESTUDIO OBSERVACIONAL POSTAUTORIZACIÓN DE SEGURIDAD (EPAS) CON VICTRELIS™ (BOCEPREVIR) EN PACIENTES CON HEPATITIS C CRÓNICA.
Datos básicos
- Protocolo:
- MER-BOC-2012-01
- EUDRACT:
- NCT:
- Centro:
- Año de incio:
- Año de finalización:
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
A multicenter study to assess the incidence of hepatocellular carcinoma recurrence after liver transplantation in patients treated with direct-acting antivirals for chronic hepatitis C
Gorgen, A; (...); Sapisochin, G
Meeting Abstract. 2018
Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11).
Garcia Morales, Natalia; (...); Cubiella, Joaquin
Article. 10.1016/j.gastrohep.2024.502220. 2024
Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
Andacoglu, Oya; (...); Selzner, Nazia
Article. 10.3389/ti.2023.11240. 2023
ADVERSE EFFECTS OF TRIPLE THERAPY WITH BOCEPREVIR (BOC) AND TELAPREVIR (TVR) IN CLINICAL PRACTICE IN PATIENTS WITH ADVANCED HEPATIC FIBROSIS
Salmeron, J.; (...); Prieto, M.
Article. 10.1016/S0168-8278(14)61356-8. 2014
Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis
Diaz, FC; (...); Prieto, M
Article. 10.5604/16652681.1222114. 2016
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting The MENTE Study
Rodríguez-Nóvoa S; (...); Castro Á
Article. 10.1097/MCG.0000000000000569. 2016
Altered underlying tubular function in HBV monoinfected patients receiving nucleos(t)ide analogs in a real-world setting: MENTE Study
Rodriguez Novoa, Sonia; (...); Castro, Angeles
Article. 2014
ANABOLIC ANDROGENIC STEROIDS (AAS) ILLICIT USE IS A RAPIDLY GROWING CAUSE OF DRUG-INDUCED LIVER INJURY (DILI): A PROSPECTIVE SERIES FROM THE SPANISH-LATIN-AMERICAN DILI REGISTRY
Medina-Caliz, I.; (...); Andrade, R. J.
Article. 10.1016/S0168-8278(14)60472-4. 2014
Assessment of persistent COVID-19 in liver transplant recipients compared to immunocompetent individuals
Fernandez, A.; (...); Salcedo, M. M.
Meeting Abstract. 2023
Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation Study
Puchades, L; (...); Lai, JC
Article. 10.1097/TP.0000000000002025. 2018
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles
Stephens, C; (...); Lucena, MI
Article. 10.1097/FPC.0000000000000230. 2016
Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
Martí-Aguado D; (...); Martí-Bonmatí L
Article. 10.1148/radiol.2021211027. 2022
Avances en el tratamiento de la hepatitis C.
Vinaixa C, Aguilera V, Berenguer M
Abstract of Published Item. 10.1016/j.medcli.2013.01.041. 2013
Baseline features of hepatitis C patients associated to prescription of pangenotypic antiviral treatments: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Brain abscesses in early post-liver transplantation.
Mínguez Sabater A; (...); Prieto Castillo M
Case Reports. 10.1016/j.eimc.2021.02.002. 2021
Brain abscesses in early post-liver transplantation.
Minguez Sabater, Alejandro; (...); Prieto Castillo, Martin
Article. 10.1016/j.eimce.2021.09.007. 2021
CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Correction. 10.1016/j.rec.2023.03.018. 2023
CA125: a new biomarker in patients with Fontan circulation.
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Article. 10.1016/j.rec.2022.05.029. 2022
Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation
Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2022
Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?
Herreras, J.; (...); Aguilera, V.
Article. 2022
Clinical characteristics and outcomes of elderly included in the Spanish Drug-Induced Liver Injury (DILI) Registry
Slim, M; (...); Andrade, RJ
Meeting Abstract. 10.1016/S0168-8278(17)31154-6. 2017
Clinical features and risk factors associated with Non-alcoholic steatohepatitis (NASH) in Spain. On behalf of HEPAmet Registry
Gallego-Duran, Rocio; (...); Romero-Gomez, Manuel
Article. 2015
Clinical outcomes of patients delisted from thewaiting list of liver transplantation after interferon-free antiviral therapy
Pascasio, JM; (...); Londono, MC
Meeting Abstract. 10.1016/S0168-8278(17)30661-X. 2017
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
Pascasio, JM; (...); Londoño MC
Article. 10.1016/j.jhep.2017.08.008. 2017
CLINICAL PRESENTATION AND OUTCOMES OF DE NOVO HEPATITIS B VIRUS INFECTION AFTER LIVER TRANSPLANTATION IN SPAIN.
Pascasio Acevedo, Juan Manuel; (...); Manuel Sousa, Jose
Meeting Abstract. 2019
CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)
Aguilera, V.; (...); Berenguer, M.
Meeting Abstract. 2023
CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation.
Aguilera V; (...); Mir J
Article. 10.1016/S1665-2681(19)31366-3. 2013
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry.
Stephens C; (...); Andrade RJ
Article. 10.1016/j.jhep.2021.01.029. 2021
Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020).
Rodríguez M; (...); García-Samaniego J
Article. 10.1016/j.gastrohep.2020.03.011. 2020
Control of Diabetes Mellitus in Liver Transplant Recipients
Ramos-Prol, Agustin; (...); Francisco Merino-Torres, Juan
Article. 2014
COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey
Vinaixa, Carmen; (...); Berenguer, Marina
Meeting Abstract. 2022
COVID vaccination among liver transplant recipients: an EASL-ESOT/ELITA-ILTS multi-society international survey
Vinaixa, C.; (...); Berenguer, M.
Meeting Abstract. 2022
Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study
Aguilera, V; (...); Berenguer, M
Article. 10.1111/tri.13145. 2018
Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation
Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel
Meeting Abstract. 2023
CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation.
Carvalho-Gomes Â; (...); López-Labrador FX
Article. 10.1016/j.cellimm.2021.104455. 2022
Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
Marcos, AC; (...); Pons, JA
Meeting Abstract. 2021
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
Caballero-Marcos, A; (...); Pons, JA
Article. 10.1111/ajt.16599. 2021
Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)
Di Maira, T; (...); European Liver & Intestine
Meeting Abstract. 2021
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry
Berenguer M; (...); European Liver Intestine Transplan
Article. 10.1097/TP.0000000000003542. 2021
CHARACTERIZATION OF HBsAg LOSS IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH NUCLEOS/TIDE ANALOGS (NUCS): A RETROSPECTIVE MULTICENTER STUDY (HEBESAS)
Suarez, E.; (...); Fuentes, J.
Article. 10.1016/S0168-8278(15)30854-0. 2015
Chronic kidney disease after liver transplantation: pretransplantation risk factors and predictors during follow-up.
Giusto M; (...); Merli M
Article. 10.1097/TP.0b013e3182884890. 2013
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection
Fontana RJ; (...); Reddy KR
Article. 10.1002/lt.24416. 2016
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019.
Caballero-Marcos, Aranzazu; (...); Salcedo, Magdalena
Article. 10.1002/lt.26389. 2022
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Chen Q; (...); Quer J
Article. 10.1016/j.antiviral.2019.104694. 2020
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Medina-Caliz, I; (...); Spanish DILI Registry
Article. 10.1016/j.jhep.2016.05.003. 2016
Delisting of Liver Transplant Candidates with Chronic HCV Infection after Viral Erradication: Outcome 2 Years after Delisting. A European Study
Vinaixa, C; (...); Duvuox, C
Meeting Abstract. 10.1097/01.tp.0000542536.91165.49. 2018
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
Belli LS; (...); European Liver and Intestine Association (ELITA)
Article. 10.1016/j.jhep.2016.05.010. 2016
Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study
Belli, LS; (...); Duvoux, C
Meeting Abstract. 10.1016/S0168-8278(17)30339-2. 2017
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1111/liv.15766. 2024
Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.3390/biom11121808. 2021
Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1111/apt.16100. 2021
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
Manzardo, C; (...); FIPSE LT-HIV Investigators
Article. 10.1111/ajt.14996. 2018
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)
Manzardo, C.; (...); Samuel, D.
Article. 2018
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)
Manzardo, C.; (...); Samuel, D.
Correction. 10.1111/ajt.15244. 2019
Disease Reversibility in Patients With Post-Hepatitis C Cirrhosis: Is the Point of No Return the Same Before and After Liver Transplantation? A Review
Vinaixa, C, Strasser, SI, Berenguer, M
Review. 10.1097/TP.0000000000001633. 2017
Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids
Robles-Diaz M; (...); SLatinDILI Network
Article. 10.1111/apt.13023. 2015
DISTINGUISHING DRUG INDUCED AUTOIMMUNE HEPATITIS FROM IDIOPATIC AUTOIMMUNE HEPATITIS
Ortega-Alonso, A.; (...); Lucena, M. I.
Article. 10.1016/S0168-8278(15)31294-0. 2015
Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?
Trapero-Marugan, M.; (...); Cuervas-Mons, V.
Meeting Abstract. 2023
DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome
Medina-Caliz, I; (...); Andrade, RJ
Meeting Abstract. 10.1016/S0168-8278(18)31459-4. 2018
Early Introduction of Subcutaneous Hepatitis B Immunoglobulin Following Liver Transplantation for Hepatitis B Virus Infection: A Prospective, Multicenter Study
De Simone, P; (...); Samuel, D
Article. 10.1097/TP.0000000000001171. 2016
Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2023
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
Salmerón J; (...); Quiles R
Article. 10.3748/wjg.v21.i30.9163. 2015
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir +/- dasabuvir +/- ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Perello, C; (...); Spanish Collaborative Group for the Study of the Use of Hepatitis C Direct-Actin
Article. 10.1111/jvh.12637. 2017
Effectiveness of 8 weeks of glecaprevir/pibrentasvir in treatment-naive hepatitis C patients with liver cirrhosis: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice
Ruiz-Antoran, B; (...); Panero, JLC
Meeting Abstract. 10.1016/S0168-8278(17)31448-4. 2017
EFFECTIVENESS OF TRIPLE THERAPY WITH BOCEPREVIR OR TELAPREVIR IN A MULTICENTRE CLINICAL PRACTICE COHORT OF HCV TREATMENT-EXPERIENCED PATIENTS WITH ADVANCED HEPATIC FIBROSIS. SVR-12W AFTER TREATMENT
FERNANDEZ, C.; (...); Salmeron, J.
Article. 10.1016/S0168-8278(14)61360-X. 2014
Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice - preliminary data Vie-KinD study
Londono, MC; (...); De Alvaro, C
Meeting Abstract. 10.1016/S0168-8278(17)31920-7. 2017
Effects of high-resolution esophageal manometry on oxygen saturation and hemodynamic function
Ortiz, V; (...); Garrigues, V
Article. 10.1111/dote.12523. 2017
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Salcedo, M; (...); Bañares R
Article. 10.1111/tri.12999. 2017
Efficacy and safety of glecaprevir/pibrentasvir for the pangenotypic treatment of chronic hepatitis C in former intravenous drug users: Subanalysis from a Spanish real-world cohort (Hepa-C)
Puigvehi, M; (...); Carrion, JA
Meeting Abstract. 10.1016/S0618-8278(19)30399-8. 2019
Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort
Sanchez Antolin G; (...); Castells L
Article. 10.1016/j.transproceed.2016.08.034. 2016
Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C
Fernández I; (...); Londoño MC
Article. 10.1016/j.jhep.2016.12.020. 2017
Efficacy of retreatment of HCV infection after liver transplantation (lt): role of aggressive approach
Berenguer, Marina; (...); Samuel, Didier
Article. 2012
Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: Role of an aggressive approach
Berenguer, Marina; (...); Samuel, Didier
Article. 2013
Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: role of an aggressive approach.
Berenguer M; (...); Samuel D
Article. 10.1002/lt.23555. 2013
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities
Buti M; (...); Gila A
Article. 10.1097/MEG.0000000000000195. 2015
Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients.
Colmenero J; (...); Pons JA
Article. 10.1016/j.jhep.2020.07.040. 2021
Ertapenem neurotoxicity in liver transplantation.
Martinez Delgado, Sara; (...); Conde, Isabel
Article. 10.17235/reed.2021.8469/2021. 2022
Estrategias para evitar la recidiva viral B despues del trasplante hepatico.
Abstract of Published Item. 10.1016/S0210-5705(14)70067-6. 2014
Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference.
Salcedo, Magdalena; (...); Line, Pal-Dag
Article. 10.1097/TP.0000000000003997. 2022
Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.
Gómez-Bravo M; (...); Santoyo J
Article. 10.17235/reed.2022.8549/2021. 2022
Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients
Sahuco, Ivan; (...); Berenguer, Marina
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1002/ueg2.12571. 2024
Fat and liver transplantation: clinical implications
Vinaixa, C, Selzner, N, Berenguer, M
Review. 10.1111/tri.13288. 2018
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.
Martinez-Arenas, Laura; (...); Berenguer, Marina
Article. 10.1111/liv.16085. 2024
FIRST REAL CLINICAL PRACTICE DATA IN SPAIN ON SOFOSBUVIR, SIMEPREVIR AND DACLATASVIR IN POST-TRANSPLANT HCV RECURRENCE: THE HepatiC REGISTRY EXPERIENCE
Prieto, M.; (...); Forns, X.
Article. 10.1016/S0168-8278(15)30988-0. 2015
Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.1002/lt.24128. 2015
GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study.
Rodríguez-Perálvarez ML; (...); Gastaca M
Article. 10.1016/j.eclinm.2024.102737. 2024
GENDER AND RACIAL DISCRIMINATION AMONG LIVER TRANSPLANTATION PROFESSIONALS: A SURVEY FROM ILTS EDI COMMITTEE
Andacoglu, Oya; (...); Selzner, Nazia
Meeting Abstract. 2021
Gender and racial discrimination among liver transplantation professionals: report of a global survey
Aguilera, V.; (...); Selzner, N.
Article. 2022
Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey
Aguilera, Victoria; (...); Selzner, Nazia
Article. 10.3389/ti.2022.10506. 2022
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, Isabel; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria
de la Varga, MF; (...); Castillo, MP
Meeting Abstract. 2021
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria
Article. 10.1016/j.aohep.2022.100724. 2022
Haemophagocytic syndrome in a liver transplant patient during treatment with Telaprevir.
Rodríguez-Medina B; (...); Berenguer M
Article. 10.1016/S1665-2681(19)31305-5. 2013
HCV cirrhosis: liver volume as a non-invasive predictor of liver recovery post DAA treatment
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 10.1016/S0168-8278(17)31568-4. 2017
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients
Suarez, E; (...); Simon, MA
Article. 10.1097/MEG.0000000000001289. 2019
Hepatitis B virus quasispecies evolution after liver transplantation in patients under long-term lamivudine prophylaxis with or without hepatitis B immune globulin
Buti M; (...); Esteban R
Article. 10.1111/tid.12360. 2015
Hepatitis B virus recurrence after liver transplantation and evolution of viral quasispecies
Buti, Maria; (...); Rodriguez-Frias, Francisco
Article. 2014
Hepatitis C Virus Recurrence After Liver Transplantation: How to Treat and When
Article. 10.1016/j.transproceed.2014.09.177. 2014
Hepatitis C-related cirrhosis: Current status
Conde, I, Vinaixa, C, Berenguer, M
Review. 10.1016/j.medcli.2016.09.019. 2017
Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19
Del Hoyo, J.; (...); Aguilera, V
Editorial Material. 2020
Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19.
Del Hoyo J; (...); Aguilera V
Editorial Material. 10.1111/jgh.15174. 2020
Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC)
Gratacos-Gines, Jordi; (...); Pose, Elisa
Meeting Abstract. 2024
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4
Mariño Z; (...); Forns, X
Article. 10.1111/liv.13470. 2017
HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study
Vinaixa, C.; (...); Prieto, M.
Meeting Abstract. 2019
HIV Infection Is Not Associated with Increased Cardiovascular Risk in Liver Transplant Recipients: A Single Center Comparative Study
Herreras, J; (...); Berenguer, M
Meeting Abstract. 2018
Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study
Aguero, F; (...); FIPSE Investigators
Article. 10.1002/lt.24741. 2017
Iberogast-Induced Severe Hepatotoxicity Leading to Liver Transplantation
Sáez-González E; (...); Berenguer M
Letter. 10.1038/ajg.2016.260. 2016
IDENTIFICATION OF CANDIDATES FOR MASLD TREATMENT WITH INDETERMINATE VIBRATION- CONTROLLED TRANSIENT ELASTOGRAPHY
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1016/j.cgh.2024.10.014. 2024
IMPACT OF ANTICOAGULANT THERAPY ON UPPER GASTROINTESTINAL BLEEDING (UGI) IN PATIENTS WITH LIVER CIRRHOSIS. RESULTS FROM A RETROSPECTIVE MULTICENTRIC CASE-CONTROL STUDY
Cerini, F.; (...); Garcia-Pagan, J. C.
Article. 10.1016/S0168-8278(14)60019-2. 2014
Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study
Cerini F; (...); Garcia-Pagán JC
Article. 10.1002/hep.27783. 2015
Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT)
Saez-Gonzalez, E; (...); Berenguer, M
Article. 10.1111/liv.13618. 2018
Improved Renal Function in Liver Transplant Recipients Treated for Hepatitis C Virus With a Sustained Virological Response and Mild Chronic Kidney Disease
Blé M; (...); Berenguer M
Article. 10.1002/lt.23756. 2014
Inadequate social support decreases survival in decompensated liver cirrhosis patients.
García Morales N; (...); Cubiella, Joaquin
Article. 10.1016/j.gastrohep.2022.04.006. 2022
Incidence and prognostic impact of cancer after liver transplantation
Gastaca, M; (...); Rodriguez-Peralvarez, M
Meeting Abstract. 2021
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2023
Increased cardiovascular risk post-LT in HIV-infected patients? An ELTR based multicenter study
Vinaixa, C.; (...); Aguilera, M. V.
Meeting Abstract. 2024
Interferon-free therapy is effective and safe for hepatitis C recurrence in liver transplant hepatitis C virus/human immunodeficiency virus coinfected recipients: a case-control study
Londono, MC; (...); FIPSE Investigators
Meeting Abstract. 10.1016/S0168-8278(17)30669-4. 2017
Is hepatitis B immunoglobulin necessary for hepatitis D prophylaxis after liver transplantation? A retrospective multicenter study of a cohort of 174 patients
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Meeting Abstract. 2020
Kinetics of Cytomegalovirus Specific Polyfunctional T-Cell Responses Associated with Control of CMV Reactivation after Liver Transplantation.
Carvalho-Gomes, A; (...); Lopez-Labrador, FX
Meeting Abstract. 2018
Lack of effect of CMV reactivation in the outcome of HCV-infected liver transplant(LT)patients
Aguilera, Victoria; (...); Berenguer, Marina
Article. 2015
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial
Manns, M; (...); SOLAR-2 Investigators
Article. 10.1016/S1473-3099(16)00052-9. 2016
LIPID DROPLET MORPHOLOGY JUSTIFIES DISCORDANCES BETWEEN HEPATIC STEATOSIS GRADES AND MRI PROTON DENSITY FAT FRACTION
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Liver transplant for porto-sinusoidal vascular disease (psvd): long-term outcome
Magaz, M; (...); Valdig
Meeting Abstract. 2021
Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1097/TP.0000000000004444. 2022
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Long-Term Complications After Liver Transplantation: Results at 15 Years After Transplantation
Berenguer, Marina; (...); Prieto, Martn
Article. 2015
Long-Term Effectiveness, Safety, and Patient- Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
Roche B; (...); Samuel D
Article. 10.12659/AOT.936162. 2022
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Long-term outcome of "long-term liver transplant survivors"
Berenguer, Marina; (...); Prieto, Martin
Article. 2012
Long-term outcome of 'long-term liver transplant survivors'.
Rubín A; (...); Berenguer M
Article. 10.1111/tri.12118. 2013
MAGNETIC RESONANCE IMAGING-BASED BIOMARKER ACCURATELY IDENTIFIES PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND CLINICALLY SIGNIFICANT LIVER FIBROSIS: A MULTICENTER, INTERNATIONAL, VALIDATION STUDY
Arnouk, Joud; (...); Marti-Bonmati, Luis
Meeting Abstract. 2021
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.
Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria
Article. 10.1016/j.trre.2024.100875. 2024
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?
Herreras Lopez, Julia; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8384/2021. 2022
Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation.
Herreras J; (...); Berenguer M
Article. 10.1097/TXD.0000000000000934. 2019
MRI-PDFF captures the whole spectrum of lipid composition beyond traditional histological evaluation of macrosteatosis
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2023
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Riveiro-Barciela, Mar; (...); Esteban, Rafael
Article. 10.1016/j.gastrohep.2023.01.010. 2023
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors
Martin-Mateos, R.; (...); Albillos, A.
Meeting Abstract. 2024
New concepts and best practices for management of pre- and post-transplantation cancer.
Campistol JM; (...); Ussetti P
Article. 10.1016/j.trre.2012.07.001. 2012
Open wound and cutaneous fistulization after microwave ablation of hepatocarcinoma.
Ladron Abia, Pablo; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8663/2022. 2022
Out of Milan criteria and worse intetion to treat results at large liver transplant center
Lopez, JH; (...); Haym, MB
Meeting Abstract. 10.1016/S0168-8278(18)30613-5. 2018
Outcome of liver transplant candidates "delisted" after successful treatment of HCV infection
Perricone, G; (...); ELITA
Meeting Abstract. 2018
Out-of-Milan criteria and worse intention-to-treat results at a large liver transplant (LT) centre
Herreras, J; (...); Berenguer, M
Meeting Abstract. 2018
Out-of-Milan HCC criteria and worse intention-to-treat results following liver transplantation
Herreras, J.; (...); Berenguer, M.
Meeting Abstract. 2019
OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS
Carvalho-Gomes, Angela; (...); Berenguer, Marina
Meeting Abstract. 2022
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.
Marti-Aguado D; (...); Marti-Bonmati L
Article. 10.3389/fendo.2023.1213441. 2023
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
Castells L; (...); FIPSE LT-HIV Investigators
Article. 10.1016/j.jhep.2014.07.034. 2015
Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance
Pallares, C; (...); Lopez-Labrador, FX
Article. 10.1016/j.jcv.2018.02.016. 2018
Periesophageal Lymph Node Metastasis of Prostate Adenocarcinoma From Liver Transplant Donor
Sanchez-Montes, C; (...); Arguello, L
Editorial Material. 10.14309/ajg.0000000000000135. 2019
Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
Vinaixa, C; (...); Prieto, M
Letter. 10.1002/lt.25297. 2018
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
Editorial Material. 10.5604/16652681.1235470. 2017
Phenotypic and genotypic characterization of drug-induced liver injury (DILI) with autoimmune features
Stephens, C.; (...); Andrade, Raul J.
Article. 2015
Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infection
Pallares, C; (...); Berenguer, M
Meeting Abstract. 10.1016/S0168-8278(17)31165-0. 2017
Population screening using a point-of-care test reveals unexpectedly low prevalence of active HCV infection in Spain
Carvalho-Gomes, A; (...); Berenguer, M
Meeting Abstract. 2017
Porto sinusoidal vascular liver disorder: natural history and long-term outcome
Magaz, Marta; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1016/j.jhep.2024.07.035. 2024
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; (...); Berenguer M
Article. 10.1016/j.aohep.2019.06.014. 2019
PREDICTIVE FACTORS OF SURVIVAL AND PROGNOSTIC SCORE VALIDATION IN LIVER RETRANSPLANTATION FOR SEVERE HEPATITIS C RECURRENCE: THE IMPORTANCE OF HCV THERAPY BEFORE AND AFTER RETRANSPLANTATION
Song, A. T. W.; (...); Samuel, D.
Article. 10.1016/S0168-8278(13)60186-5. 2013
Pre-Immunosuppressant Hepatitis B Virus Screening Practices Among Various Medical Specialities (HEBRA Project): Results of a Survey from 19 Spanish Hospitals
Garcia-Bengoechea, Manuel; (...); Esteban, Rafael
Article. 2012
Proceedings of the 25th Annual Congress of the International Liver Transplantation Society.
Chadha R; (...); Bhangui P
Review. 10.1097/TP.0000000000003160. 2020
Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society.
Kalisvaart, Marit; (...); Kirchner, Varvara
Article. 10.1097/TP.0000000000004183. 2022
Proceedings of the 27th Annual Congress of the International Liver Transplantation Society.
Campos-Varela, Isabel; (...); De Martin, Eleonora
Article. 10.1097/TP.0000000000004637. 2023
Proceedings of the 28th annual congress of the international liver transplantation society.
Shaji Mathew, Johns; (...); Chadha, Ryan
Article. 10.1097/LVT.0000000000000330. 2024
Proceedings of the 29th Annual Congress of the International Liver Transplantation Society.
Patel, Madhukar S; (...); Rammohan, Ashwin
Article. 10.1097/LVT.0000000000000593. 2025
Prognosis of severe HBV reactivation in Western countries: role of the MELD score
Poli, E; (...); Coilly, A
Meeting Abstract. 2021
Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence
Montalva EM; (...); Lopez-Andujar R
Article. 10.1016/j.transproceed.2016.07.033. 2016
Progress in hepatitis C treatment
Vinaixa, Carmen, Aguilera, Victoria, Berenguer, Marina
Review. 2013
Protease inhibitors impair renal function in HCV-infected immunocompetent patients
Fernandez-Carrillo, Carlos; (...); Luis Calleja, Jose
Meeting Abstract. 2014
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
Buti, M; (...); Esteban, R
Article. 10.1371/journal.pone.0184550. 2017
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
Crespo, J; (...); Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collab
Article. 10.1016/j.cgh.2017.02.020. 2017
Recommendations of everolimus use in liver transplant
Rubin Suarez, Angel; (...); Prieto Castillo, Martin
Review. 10.1016/j.gastrohep.2017.05.008. 2017
Recompensation following an episode of alcohol-associated hepatitis mostly occurs in the first year of follow-up and is related to Child-Pugh score, levels of GGT and platelets, and alcohol abstinence
Gratacos, Jordi; (...); Pose, Elisa
Meeting Abstract. 2023
Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments
Giuliani, Tommaso; (...); Lopez-Andujar, Rafael
Article. 10.1159/000539460. 2024
Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.
Gratacos-Gines, Jordi; (...); Pose, Elisa
Article. 10.1097/HEP.0000000000000825. 2024
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial
Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Safety and Efficacy of Interferon-free Antiviral Treatment in Patients with MELD over 20
Vinaixa, C; (...); Berenguer, M
Meeting Abstract. 2017
Sexual Dysfunction in Cirrhotic Patients Awaiting Liver Transplantation.
Rodriguez-Medina, Beatriz; (...); Berenguer, Marina
Article. 2013
SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA
de la Varga, MF; (...); Aguilera, V
Meeting Abstract. 2021
Sinusoidal Obstruction Syndrome after Liver Transplantation: A Multicenter Observational Study.
Caballero-Marcos A; (...); Salcedo M
Article. 10.1002/lt.26452. 2022
Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent Hepatitis C After Liver Transplantation
Forns X; (...); Habersetzer F
Article. 10.1002/hep.27681. 2015
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?
Cabezas, Joaquin; (...); Crespo Garcia, Javier
Meeting Abstract. 2023
TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)
Buti, M.; (...); Esteban, R.
Article. 10.1016/S0168-8278(14)61200-9. 2014
TENOFOVIR MONOTHERAPY VERSUS LAMIVUDINE PLUS ADEFOVIR IN LAMIVUDINE-FAILURE PATIENTS RESCUED WITH LAMIVUDINE PLUS ADEFOVIR COMBINATION: INTERIM ANALYSIS OF THE TENOSIMP-B CLINICAL TRIAL
Jorquera, F.; (...); Rodriguez, M.
Article. 10.1016/S0168-8278(14)61201-0. 2014
Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study
Rodriguez, M; (...); TENOSIMP-B Res Grp
Article. 10.3748/wjg.v23.i41.7459. 2017
The 2024 ILTS-ILCA consensus recommendations for liver transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Kodali, Sudha; (...); Sapisochin, Gonzalo
Article. 10.1097/LVT.0000000000000589. 2025
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
Young, J; (...); Calleja, JL
Article. 10.1186/s12879-016-2106-x. 2017
The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
THE IMPACT OF DIRECT ACTING ANTIVIRALS ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC RETROSPECTIVE STUDY
Gorgen, A; (...); Sapisochin, G
Meeting Abstract. 2019
The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study
Gorgen, A; (...); Sapisochin, G
Article. 10.1097/TP.0000000000003115. 2020
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients
Roman A; (...); Ussetti P
Article. 10.1016/j.trre.2014.01.001. 2014
The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC)
Gratacos-Gines, Jordi; (...); Pose, Elisa
Meeting Abstract. 2024
THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION
Herreras, J; (...); Aguilera, V
Meeting Abstract. 2021
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Article. 10.1111/liv.15777. 2024
The role of prehabilitation on short-term outcomes after liver transplantation - A review of the literature and expert panel recommendations.
Vinaixa C; (...); Samuel D
Article. 10.1111/ctr.14686. 2022
The use of prophylactic strategies using hepatitis B immunoglobulin for hepatitis B recurrence after liver transplantation in routine clinical practice in Spain. Preliminary results of the 1st round of a delphi panel
Prieto, M; (...); Casado, MA
Meeting Abstract. 10.1016/S0168-8278(17)30671-2. 2017
Treatment of Hepatitis C Virus Infection in Patients With Cirrhosis and Predictive Value of Model for End-Stage Liver Disease: Analysis of Data From the Hepa-C Registry
Fernández Carrillo C; (...); Calleja, JL
Article. 10.1002/hep.29097. 2017
Trends in liver transplantation for acute liver failure: a Spanish multicenter study
Conde, I.; (...); Berenguer, M.
Meeting Abstract. 2022
Triple Therapy for HCV Cirrhosis in Liver Transplant Candidates. High Rate of Prevention of HCV Recurrence after Liver Transplantation (LT) in Well Selected Patients
Maria Braithwaite, Ana; (...); Berenguer, Marina
Article. 2014
T-tube or no T-tube in cadaveric orthotopic liver transplantation: the eternal dilemma: results of a prospective and randomized clinical trial.
López-Andújar R; (...); De Juan Burgueño M
Article. 10.1097/SLA.0b013e318286e0a0. 2013
Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection
Cabezas, J; (...); Crespo, J
Meeting Abstract. 10.1016/S0618-8278(19)30970-3. 2019
Use of artificial intelligence as an innovative donor-recipient matching model for liver transplantation: Results from a multicenter Spanish study
Briceño J; (...); de la Mata M
Article. 10.1016/j.jhep.2014.05.039. 2014
Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey
Vinaixa, C.; (...); Terrault, N.
Meeting Abstract. 2024
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.
Vinaixa, Carmen; (...); Berenguer, Marina
Article. 10.1097/LVT.0000000000000432. 2024
Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
Robles-Diaz M; (...); Safer and Faster Evidence-based Translation Consortium
Article. 10.1053/j.gastro.2014.03.050. 2014
Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain
Rodriguez-Peralvarez, Manuel; (...); Gastaca, Mikel
Meeting Abstract. 2024
Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications
Garcia Garcia, S.; (...); Aguilera, V.
Meeting Abstract. 2023
VI consensus document by the Spanish Liver Transplantation Society
Pardo, F; (...); Briceno, J
Article. 10.1016/j.ciresp.2017.12.013. 2018
VI consensus document by the Spanish Liver Transplantation Society
Pardo, F; (...); Briceno, J
Article. 10.1016/j.gastrohep.2018.05.012. 2018
Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.3389/frtra.2023.1332616. 2023